ChemoCentryx Inc reports results for the quarter ended in June - Earnings Summary

Churchill Capital XI

10/08/2022 20:06

* ChemoCentryx Inc  CCXI.OQ  reported a quarterly adjusted
loss
of 44 cents​​ per share for the quarter ended in June. The mean
expectation of eight analysts for the quarter was for a loss
of 49 cents per share.
    * Revenue rose 548.8% to $11.76 million from a year ago;
analysts
expected $12.66 million. 
    * ChemoCentryx Inc's reported EPS for the quarter was a loss
of 44
cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.8%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * ChemoCentryx Inc shares had risen by 105.0% this
quarter and
gained 39.5% so far this year.
    * The company reported a quarterly loss of $31.65 million.
    * Wall Street's median 12-month price target for
ChemoCentryx Inc
is $52.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 8
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 10
at 07:05 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.49          -0.44          Beat
 Mar. 31 2022      -0.31          -0.55          Missed
 Dec. 31 2021      -0.58          -0.58          Met
 Sep. 30 2021      -0.45          -0.32          Beat